University Hospital - Dpt. of Nuclear Medicine
Welcome,         Profile    Billing    Logout  
 1 Trial 
8 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Chin, Joseph
NCT04644822: Safety and Efficacy of [18F]PSMA-1007 Injection in Suspected Persistent or Recurrent Prostate Cancer.

Completed
3
100
Canada
[18F] PSMA-1007 Injection
Centre for Probe Development and Commercialization, McDougall Scientific Ltd.
Prostate Cancer Recurrent, Recurrent Prostate Cancer
01/24
01/24
PATRON, NCT04557501: PSMA PET/CT Guided Intensification of Therapy in Patients at Risk of Advanced Prostate Cancer

Active, not recruiting
3
800
Canada
PSMA PET/CT guided intensification of therapy, Control Arm
Centre hospitalier de l'Université de Montréal (CHUM), Canadian Cancer Society (CCS), Lantheus Medical Imaging, British Columbia Cancer Agency, London Health Sciences Centre, Princess Margaret Hospital, Canada, Tom Baker Cancer Centre, McMaster University, Institute of Health Economics, Canada, Queen's University
Prostate Cancer
01/29
01/29
IGPC-5, NCT04053842: Multi-modality Imaging (PCa) Using Sodium MRI and PSMA PET in Men Pre-prostatectomy

Recruiting
2
45
Canada
PET Scan, PSMA PET, [18F]PSMA-1007 Injection, PSMA, Sodium MRI, Multiparametric MRI, mpMRI
Glenn Bauman, Western University, Canada, United States Department of Defense, Centre for Probe Development and Commercialization
Prostate Cancer, Prostate Adenocarcinoma, Prostate Neoplasm
07/24
08/24
NCT03945162: Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients

Recruiting
2
125
Canada, US
Ruvidar® (TLD-1433) Bladder infusion and PDT
Theralase® Technologies Inc., University Health Network, Toronto, Pharma eMarket
Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG
06/25
12/25
TRACK, NCT02921373: Tracking Peripheral Blood Mononuclear Cells With Fluorine MRI

Withdrawn
1
12
Canada
19F Cell Sense-labeled PBMC, MRI
Gregory A. Dekaban, Western University, Canada, Ontario Institute for Cancer Research
Adverse Reaction to Diagnostic Agents and Kits Nos
06/22
12/22
CAPTAIN, NCT05027477: A Comparison of TULSA Procedure vs. Radical Prostatectomy in Participants With Localized Prostate Cancer

Recruiting
N/A
201
Europe, Canada, US
Radical Prostatectomy, TULSA Procedure, TULSA-PRO
Profound Medical Inc.
Prostate Cancer, Prostate Adenocarcinoma
12/24
12/34
NCT03718260: PSMA-PET Registry for Recurrent Prostate Cancer

Recruiting
N/A
3070
Canada
[18F]-DCFPyL PET/ CT scan (PSMA PET)
Lawson Health Research Institute, Cancer Care Ontario, Centre for Probe Development and Commercialization
Recurrent Prostate Cancer
03/24
12/25
RADICALPC, NCT03127631: A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients

Recruiting
N/A
6000
Canada, US, RoW
Nutrition, Exercise, Smoking cessation, Statin (such as Simvastatin, Atorvastatin, Rosuvastatin, Pravastatin), ACE inhibitor
McMaster University, Prostate Cancer Canada, Canadian Cancer Society (CCS)
Prostate Cancer, Cardiovascular Disease
12/26
12/26
Rachinsky, Irina
No trials found
Driedger, Albert
No trials found
Moussa, Madeleine
No trials found

Download Options